Indeed, the blockade of the CCL2-C-C Motif Chemokine Receptor 2 (CCR2) axis, involved in breast cancer cell metastatic seeding in the lungs and recruitment of metastasis-associated macrophages (300), has provided therapeutic benefit in fibrosarcoma models (301). This evidence concerns the gene CCR2 and breast carcinoma.